| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |